Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.
Press releases published on August 1, 2025
'I Believe in Santa Claus and I Believe in God' by J. Lynn Currie is a Conversation on Faith, Doubt, and Wonder
EIN Presswire
·
August 1, 2025
A story of how a man wandered through seasons of doubt and came back to faith. CANTON, MA, UNITED STATES, August 1, 2025 /EINPresswire.com/ -- In a world still reeling from uncertainty, whether from global conflict or economic instability, many people …
Hilltop Bio Welcomes Dr. Marc Bordelon as Director of Technical Services
EIN Presswire
·
August 1, 2025
New addition strengthens company’s focus on research, development, and innovation in the companion animal space. NORWOOD, MA, UNITED STATES, August 1, 2025 /EINPresswire.com/ -- Hilltop Bio, a veterinary regenerative medicine company committed to …
Spyre Therapeutics Announces Grants of Inducement Awards
GlobeNewswire
·
August 1, 2025
WALTHAM, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, dose optimization and rational therapeutic …
DIH Holding US, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
GlobeNewswire
·
August 1, 2025
NORWELL, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. (“DIH” or the “Company”) (NASDAQ:DHAI) received a notice on July 29, 2025, from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”), which stated that the Company …
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
WALTHAM, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …
Boston Beer Company Announces CEO Transition
GlobeNewswire
·
August 1, 2025
Boston, Aug. 01, 2025 (GLOBE NEWSWIRE) -- The Boston Beer Company (NYSE: SAM) today announced a leadership change effective August 15, 2025. Michael Spillane has decided to step down as CEO to focus on important personal matters. He will remain on the …
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted four newly-hired employees options to purchase an …
Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
August 1, 2025
CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the closing of its underwritten …
Soofa Announces Q3 Launch of Groundbreaking ZerOOH™ - A 75 Inch Full-Color Zero-Carbon Street Kiosk
EIN Presswire
·
August 1, 2025
Affordable, Sustainable Alternative to Traditional Powered Out of Home Ad Kiosks CAMBRIDGE, MA, UNITED STATES, August 1, 2025 /EINPresswire.com/ -- Cambridge, MA July 31, 2025 Soofa, a leading innovator in smart city infrastructure, today announced the …
Stop & Shop’s Annual Register Campaign Designed to Combat Student Hunger Returns this August
GlobeNewswire
·
August 1, 2025
QUINCY, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Stop …
Global Outpatient Clinics Market Sees Shift Toward Tech-Driven Patient Care
GlobeNewswire
·
August 1, 2025
Boston, Aug. 01, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Global Outpatient Clinics Market” is expected to grow from $4.4 trillion in 2024 to $6.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of …
BREAKING: Fluor Corp. Shares Down Over 20%; Investors Should Contact Block & Leviton to Potentially Recover Losses
GlobeNewswire
·
August 1, 2025
BOSTON, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Block …
Stran & Company to Announce Second Quarter 2025 Financial Results and Business Update Conference Call
GlobeNewswire
·
August 1, 2025
Quincy, MA, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Stran …
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
CHARLESTOWN, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 55,450 restricted …
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 1, 2025
CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that on August 1, 2025, it awarded …